Pyrrolidine and piperidine compounds
US11655235B2 · kind B2 · utility
0Cited by
15References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2020 |
| Grant date | May 23, 2023 |
| Priority date | — |
| Expiry date | Mar 19, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present technology provides pyrrolidine and piperidine compounds or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. In particular, said compounds may be usefully applied in the treatment and prevention of FAP-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.